189 related articles for article (PubMed ID: 27904997)
21. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
22. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis.
Horiuchi T; Yoshida T; Koshihara Y; Sakamoto H; Kanai H; Yamamoto S; Ito H
Endocr J; 1999 Oct; 46(5):643-9. PubMed ID: 10670749
[TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
[TBL] [Abstract][Full Text] [Related]
24. Galectin 3 and its binding protein in rheumatoid arthritis.
Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
[TBL] [Abstract][Full Text] [Related]
25. Clinical usefulness of basic fibroblast growth factor and E-selectin in patients with rheumatoid arthritis.
Sharaki OA; El-Guiziry DA; Abou-Zeid AA; El-Noueam KI; Helal AE; Gaballah AE
Egypt J Immunol; 2004; 11(2):91-100. PubMed ID: 16734121
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis.
Michael BNR; Kommoju V; Kavadichanda Ganapathy C; Negi VS
Rheumatol Int; 2019 Aug; 39(8):1377-1387. PubMed ID: 31201512
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis.
Lee SS; Joo YS; Kim WU; Min DJ; Min JK; Park SH; Cho CS; Kim HY
Clin Exp Rheumatol; 2001; 19(3):321-4. PubMed ID: 11407088
[TBL] [Abstract][Full Text] [Related]
28. Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis.
Andereya S; Streich N; Schmidt-Rohlfing B; Mumme T; Müller-Rath R; Schneider U
Rheumatol Int; 2006 Mar; 26(5):432-8. PubMed ID: 16001180
[TBL] [Abstract][Full Text] [Related]
29. Programmed cell death 5 correlates with disease activity and interleukin-17 in serum and synovial fluid of rheumatoid arthritis patients.
Wang JF; Guan ZP; Zhang SL; Pei Z; Chen YY; Pan H
Chin Med J (Engl); 2013 Jan; 126(2):296-9. PubMed ID: 23324280
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of detection of soluble interleukin 2 receptor alpha chain in the assessment of rheumatoid arthritis disease activity].
Xu JJ; Wang Y; Sun H; Jia RL; Zhang XW; Meng Y; Ren LL; Sun XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):975-980. PubMed ID: 30562767
[TBL] [Abstract][Full Text] [Related]
31. Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease.
Campion GV; Delmas PD; Dieppe PA
Br J Rheumatol; 1989 Oct; 28(5):393-8. PubMed ID: 2790398
[TBL] [Abstract][Full Text] [Related]
32. Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis.
Rovensky J; Imrich R; Radikova Z; Simorova E; Greguska O; Vigas M; Macho L
Endocr Regul; 2005 Jan; 39(1):1-6. PubMed ID: 16107132
[TBL] [Abstract][Full Text] [Related]
33. Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: Attenuated the production of inflammatory cytokines.
Xia L; Shen H; Lu J
Cytokine; 2015 Dec; 76(2):553-557. PubMed ID: 26159110
[TBL] [Abstract][Full Text] [Related]
34. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis.
Senolt L; Pavelka K; Housa D; Haluzík M
Cytokine; 2006 Sep; 35(5-6):247-52. PubMed ID: 17079158
[TBL] [Abstract][Full Text] [Related]
35. Plasma and synovial fluid adipocytokines in patients with rheumatoid arthritis and osteoarthritis.
Ibrahim SM; Hamdy MS; Amer N
Egypt J Immunol; 2008; 15(1):159-70. PubMed ID: 20306680
[TBL] [Abstract][Full Text] [Related]
36. IL-17 patterns in synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients.
Roşu A; Mărgăritescu C; Stepan A; Muşetescu A; Ene M
Rom J Morphol Embryol; 2012; 53(1):73-80. PubMed ID: 22395503
[TBL] [Abstract][Full Text] [Related]
37. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis.
Kida D; Yoneda M; Miyaura S; Ishimaru T; Yoshida Y; Ito T; Ishiguro N; Iwata H; Kimata K
J Rheumatol; 1999 Jun; 26(6):1230-8. PubMed ID: 10381035
[TBL] [Abstract][Full Text] [Related]
38. Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis.
Hui W; Bell M; Carroll G
Ann Rheum Dis; 1997 Mar; 56(3):184-7. PubMed ID: 9135222
[TBL] [Abstract][Full Text] [Related]
39. Soluble HLA class I antigens in serum and synovial fluid from patients with rheumatoid arthritis and other arthropathies.
Muñoz-Fernández S; Martín J; Martín-Mola E; García-Rodriguez MC; Cantalejo M; Fontán G; Ferreira A
Rheumatology (Oxford); 2001 Dec; 40(12):1365-9. PubMed ID: 11752506
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis.
Kamper EF; Kopeikina LT; Trontzas P; Kyriazis NC; Vaiopoulos G; Stavridis J
Clin Rheumatol; 1998; 17(4):318-24. PubMed ID: 9776116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
